Organogenesis Inks Full-Building Lease with Davis Cos

Organogenesis, a well-known leader in regenerative medicine, has successfully signed a full-building lease agreement with Davis Cos, a private equity firm with a strong focus on real estate investments. This significant real estate transaction involves a property located in Rhode Island, which Organogenesis will use to expand its operational capabilities. The partnership between Organogenesis and Davis Cos underscores a shared vision to support Organogenesis's growth and innovation in providing advanced healing solutions. This milestone illustrates a strategic move by Organogenesis to enhance its production infrastructure, thereby promising to meet the growing demand for regenerative medicine products. Meanwhile, Davis Cos continues to leverage its real estate prowess by supporting promising enterprises in their scaling efforts.